Abstract:
Background: The prevalences and risk factors of microalbuminuria are not full described among black African
diabetic patients. This study aimed at determining the prevalence of microalbuminuria among African diabetes
patients in Dar es Salaam, Tanzania, and relate to socio-demographic features as well as clinical parameters.
Methods: Cross sectional study on 91 Type 1 and 153 Type 2 diabetic patients. Two overnight urine samples per
patient were analysed. Albumin concentration was measured by an automated immunoturbidity assay. Average
albumin excretion rate (AER) was used and were categorised as normalbuminuria (AER < 20 ug/min),
microalbuminuria (AER 20–200 ug/min), and macroalbuminuria (AER > 200 ug/min). Information obtained also
included age, diabetes duration, sex, body mass index, blood pressure, serum total cholesterol, high-density and
low-density lipoprotein cholesterol, triglycerides, serum creatinine, and glycated hemoglobin A1c.
Results: Overall prevalence of microalbuminuria was 10.7% and macroalbuminuria 4.9%. In Type 1 patients
microalbuminuria was 12% and macroalbuminuria 1%. Among Type 2 patients, 9.8% had microalbuminuria, and
7.2% had macroalbuminuria. Type 2 patients with abnormal albumin excretion rate had significantly longer diabetes
duration 7.5 (0.2–24 yrs) than those with normal albumin excretion rate 3 (0–25 yrs), p < 0.001. Systolic and
diastolic blood pressure among Type 2 patients with abnormal albumin excretion rate were significantly higher than
in those with normal albumin excretion rate, (p < 0.001).
No significant differences in body mass index, glycaemic control, and cholesterol levels was found among patients
with normal compared with those with elevated albumin excretion rate either in Type 1 or Type 2 patients.
A stepwise multiple linear regression analysis among Type 2 patients, revealed AER (natural log AER) as the
dependent variable to be predicted by [odds ratio (95% confidence interval)] diabetes duration 0.090 (0.049, 0.131),
p < 0.0001, systolic blood pressure 0.012 (0.003–0.021), p < 0.010 and serum creatinine 0.021 (0.012, 0.030).
Conclusion: The prevalence of micro and macroalbuminuria is higher among African Type 1 patients with
relatively short diabetes duration compared with prevalences among Caucasians. In Type 2 patients, the prevalence
is in accordance with findings in Caucasians. The present study detects, however, a much lower prevalence than
previously demonstrated in studies from sub-Saharan Africa. Abnormal AER was significantly related to diabetes
duration and systolic blood pressure.